Search results
The Kaufman Assessment Battery for Children (KABC) is a clinical instrument (psychological diagnostic test) for assessing cognitive development. Its construction incorporates several recent developments in both psychological theory and statistical methodology.
Essentials of KABC-II Assessment. by Alan S. Kaufman, Elizabeth O. Lichtenberger, Elaine Fletcher-Janzen, and Nadeen L. Kaufman
- 246KB
- 30
The KABC-II is a reliable and valid measure of cognitive abilities of children ranging from ages 3-years, 0-months to 18-years, 11-months. It is a revision of the original KABC .
Jan 1, 2021 · The KABC-II (Kaufman and Kaufman 2004a) is a standardized cognitive assessment suitable for children aged 3–18. It provides age-based standardized scores, age equivalents, and percentile ranks.
- melissa.allen@lancaster.ac.uk
- KABC-II
- Klonopin (Clonazepam)
- Definition
- Description
- Relevance to Childhood Development
- Kohlberg, Lawrence
- Contribution to Understanding Childhood Development
- Description
- Level I: Preconventional Morality
- Level II: Conventional Morality
- Kolb, Bryan
- Introduction
- Accomplishments
- Contributions
- Current Involvement
▶Kaufman Assessment Battery for Children, Second Edition
LAUREN CONNELL PAVELKA University of Texas at San Antonio, San Antonio, TX, USA
Klonopin is an anticonvulsant that belongs to a class of medications called benzodiazepines, which act on the cen-tral nervous system (CNS) to produce a calming effect by producing gamma aminobutyric acid (GABA), a naturally occurring chemical in the body. The generic form of Klonopin is Clonazepam.
Klonopin is used to treat seizure disorders or panic disor-der. It can be used alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. It may also be useful in patients with absence seizures (petit mal), who have failed to respond to succinimides. Klonopin is also indicated for th...
The safety and effectiveness of using Klonopin to treat children and adolescents suffering from panic disorders or other psychiatric conditions are not well established. Though some reports claim overall efficacy in treating pediatric patients, these studies are not long-term. Most concerning is the risk of physical or psychological depen-dence. Fo...
JOHN SNAREY, ANDREA GREEN Emory University, Atlanta, GA, USA
Lawrence Kohlberg saw children and adolescents as moral philosophers, capable of forming their own moral judg-ments. His six stages of moral development, which encompassed childhood through adulthood, followed the characteristics of the Piagetian structural stage model [10]. He based these stages of sociomoral reasoning on a theory of evolving ment...
Kohlberg’s theory was developed by presenting ethical and moral dilemmas to children in a short story format, followed by questions to elicit their feelings and decisions about the character’s actions. After studying the responses, he concluded there are three levels of moral development, each with two stages, as described below.
In this initial level, children make decisions based on external consequences to their behavior, without consid-eration of the feelings of others. This level is typical of elementary school aged children. Stage 1: Punishment and Obedience Orientation Decisions are rule based to avoid punishment. The physical consequences of an action determine if i...
At this level, children shift to decision making based on rules or norms of the group to which they belong. Con-formity to the expectations of others and general social norms is most important. External rules begin to be inter-nalized. This level begins to emerge in adolescence. Stage 3: Interpersonal Conformity Sometimes referred to as the “Good-B...
TRACEY MCLELLAN University of Canterbury, Christchurch, New Zealand
Dr. Kolb is considered one of the world’s most influential neuroscientists and distinguished researchers of behav-ioral neuroscience. He is regarded as a “founding father of behavioral neuroscience” in which the focus is on the interaction of neuronal changes and behavior [1].
Dr. Kolb developed the first course in human neuropsy-chology in Canada. He was a post-doctoral fellow at the Montreal Neurological Institute at the time. Dr. Kolb’s later research on the plasticity of the brain, or how new brain cells grow, has informed many new treatments for individuals with Alzheimer’s disease, brain injury and drug abuse probl...
Dr. Kolb’s outstanding contribution was the discovery that we can grow new brain cells. He and his team demon-strated how the growth of new brain cells can restore cerebral and, therefore, behavioral functions [2]. An important focus of Dr. Kolb’s research was the identifica-tion of factors that effect the cerebral cortex in an embryo and during ea...
Currently, Dr. Bryan Kolb is a Professor in the Department of Neuroscience at the University of Lethbridge, Alberta, Canada. He also holds adjunct appointments at the Uni-versity of Calgary and the University of British Columbia. In addition, Dr. Kolb is an Associate Director of the Canadian Institute for Advanced Research, Experience-based Brain a...
The KABC-II measures the processing and cognitive abilities of children and adolescents between the ages of 3 years, 0 months and 18 years, 11 months.
People also ask
What is KABC II?
What is a K-ABC test?
What is a kabcii test?
What does KABC-II stand for?
Is the KABC-II a valid test for atypical children?
What is the difference between KABC and KABC-II?
This chapter provides an overview of two comprehensive, individually administered Kaufman tests of cognitive ability: the recently revised and restandardized second edition of the Kaufman Assessment Battery for Children (K-ABC), known as the KABC-II and the Kaufman Adolescent and Adult Intelligence Test (KAIT).
